Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × CT-P13 × 1 year × Clear all

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Colitis, Ulcerative 1

Interventions

Capecitabine 8 Bevacizumab 8 tislelizumab 7 Cisplatin 7 pembrolizumab 6 Oxaliplatin 6 Drug Therapy 6 Docetaxel 6 Carboplatin 6 Surgical Procedures, Operative 5 Radiotherapy 5 Gemcitabine 5 Fluorouracil 5 Epirubicin 5 Cyclophosphamide 5 Standard of Care 4 Saline Solution 4 Rituximab 4 Radiosurgery 4 Prednisone 4 Laparoscopy 4 Exercise 4 Control Groups 4 pertuzumab 3 durvalumab 3 anlotinib 3 Vincristine 3 Paclitaxel 3 Observation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed

Colitis, Ulcerative, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡